Market Closed -
OTC Markets
20:18:05 30/04/2024 BST
5-day change
1st Jan Change
1.2
USD
+471.16%
-.--%
+471.16%
Bioethics, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019
Bioethics, Ltd. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced operating loss was USD 18,421 compared to USD 12,873 a year ago. Net loss was USD 26,175 compared to USD 16,948 a year ago.
Bioethics, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
05-20
CI
Bioethics, Ltd. Appoints Doug Morris as A Member of Board of Directors
04-30
CI
Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
04-11
CI
Bioethics, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11-14
CI
Bioethics, Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
09/08/23
CI
Bioethics, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
19/05/23
CI
Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
17/04/23
CI
Bioethics, Ltd. Auditor Raises 'Going Concern' Doubt
16/04/23
CI
Bioethics, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
21/11/22
CI
Bioethics, Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
15/08/22
CI
Bioethics, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
23/05/22
CI
Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
15/04/22
CI
Bioethics, Ltd. Auditor Raises 'Going Concern' Doubt
14/04/22
CI
Bioethics, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
19/11/21
CI
Bioethics, Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
23/08/21
CI
Bioethics, Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
19/11/20
CI
XCR Diagnostics, Inc. entered into a non-binding term sheet to acquire Bioethics, Ltd. in a reverse merger transaction for approximately $110 million.
30/07/20
CI
Bioethics, Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
28/07/20
CI
Bioethics, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
14/05/20
CI
Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019
09/04/20
CI
Bioethics, Ltd. Announces Director Resignations
05/03/20
CI
Bioethics, Ltd. Announces Executive Changes
24/01/20
CI
Bioethics, Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019
14/11/19
CI
Bioethics, Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019
14/08/19
CI
Bioethics, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019
15/05/19
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Bioethics, Ltd. is a shell company. The Company is formed for the purpose of entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The Company has not commenced any operations nor generated any revenue.
More about the company
1st Jan change
Capi.
+471.16% 1.36M +154.80% 8.13B +2.33% 984M +41.91% 883M +18.23% 786M +2.16% 667M +5.03% 631M -.--% 600M +8.61% 528M -.--% 500M
Shell Companies
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1